Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Recursion Pharmaceuticals Inc - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Recursion Pharmaceuticals Inc - Ordinary Shares - Class A market cap is $1.97B.
What is the 52-week high for Recursion Pharmaceuticals Inc - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Recursion Pharmaceuticals Inc - Ordinary Shares - Class A 52 week high is $12.36 as of September 11, 2025.
What is the 52-week low for Recursion Pharmaceuticals Inc - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Recursion Pharmaceuticals Inc - Ordinary Shares - Class A 52 week low is $3.79 as of September 11, 2025.
What is Recursion Pharmaceuticals Inc - Ordinary Shares - Class A stock price today?
Recursion Pharmaceuticals Inc - Ordinary Shares - Class A stock price today is $4.85.
What was Recursion Pharmaceuticals Inc - Ordinary Shares - Class A stock price yesterday?
Recursion Pharmaceuticals Inc - Ordinary Shares - Class A stock price yesterday was $4.54.
What is the PE ratio of Recursion Pharmaceuticals Inc - Ordinary Shares - Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Recursion Pharmaceuticals Inc - Ordinary Shares - Class A’s P/E ratio is -2.54.
What is the Price-to-Book ratio of Recursion Pharmaceuticals Inc - Ordinary Shares - Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Recursion Pharmaceuticals Inc - Ordinary Shares - Class A P/B ratio is 2.1379.
What is the 50-day moving average of Recursion Pharmaceuticals Inc - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Recursion Pharmaceuticals Inc - Ordinary Shares - Class A 50-day moving average is $5.37.
